Skip to main content
Log in

Stage-related changes in functional capacity in Hodgkin’s disease: assessment by cardiopulmonary exercise testing before initiation of treatment

  • Original Article
  • Published:
Annals of Hematology Aims and scope Submit manuscript

Abstract

Our aim was to examine indices of cardiorespiratory capacity at rest and during exercise before initiation of therapy for Hodgkin’s disease. We prospectively studied 24 patients divided into two groups according to the disease stage. Group 1 included eight patients in stage IA and four in stage IIA; group 2 included four patients in stage IIB, six in stage III, and two in stage IV. All patients underwent detailed cardiopulmonary evaluations at rest using electrocardiogram, echocardiogram, spirometry, and measurement of pulmonary diffusing capacity (DLCO), and during exercise using a cardiopulmonary exercise test. Groups 1 and 2 were similar with respect to sex distribution (eight women and four men in each), mean age (35±36 vs37±4.6 years), body mass index, and hemoglobin concentration (12.7±0.2 vs 12.1±0.3 g l−1). All patients had a normal cardiovascular status. All patients in group 1 had normal cardiorespiratory measurements at rest and during exercise. Forced vital capacity was significantly lower in group 2 (84.8±2.7% predicted) than in group 1 (105±3%, P<0.0001), without abnormalities in DLCO or in resting and exercise oxygen diffusion. Likewise, percentage predicted \(V_{{{\text{O}}_{{2\max }} }} \) (65±4 vs 97±6, P<0.0002), oxygen pulse at peak exercise (0.12±0.01 vs 0.17±0.01, P<0.001), and \({\Delta V_{{{\text{O}}_{{\text{2}}} }} } \mathord{\left/ {\vphantom {{\Delta V_{{{\text{O}}_{{\text{2}}} }} } {\Delta {\text{W}}}}} \right. \kern-\nulldelimiterspace} {\Delta {\text{W}}}\) slope (8.4±0.3 vs 10.2±0.4, P<0.003) were significantly lower in group 2 than in group 1. Functional capacity during exercise was markedly reduced in patients suffering from Hodgkin’s disease in advanced stages. This loss of exercise capacity appeared mainly related to a peripheral disorder.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1
Fig. 2

Similar content being viewed by others

References

  1. Adams MJ, Lipsitz SR, Colan SD, Tarbell NJ, Treves ST, Diller L, Greenbaum N, Mauch P, Lipshultz SE (2004) Cardiovascular status in long-term survivors of Hodgkin’s disease treated with chest radiotherapy. J Clin Oncol 22:3139–3148

    Article  PubMed  Google Scholar 

  2. Aleman BM, Van den Belt-Dusebout AW, Klokman WJ, Van’t Veer MB, Bartelink H, Van Leeuwen FE (2003) Long-term cause-specific mortality of patients treated for Hodgkin’s disease. J Clin Oncol 21:3431–3439

    Article  PubMed  Google Scholar 

  3. Clark AL, Sparrow JL, Coats AJ (1995) Muscle fatigue and dyspnea in chronic heart failure: two sides of the same coin? Eur Heart J 16:49–52

    PubMed  CAS  Google Scholar 

  4. Dandurand RJ, Matthews PM, Arnold DL, Eidelman DH (1995) Mitochondrial disease. Pulmonary function, exercise performance, and blood lactate levels. Chest 108:182–189

    PubMed  CAS  Google Scholar 

  5. Dimeo F, Schmittel A, Fietz T, Schwartz S, Köhler P, Böning D, Thiel E (2004) Physical performance, depression, immune status and fatigue in patients with hematological malignancies after treatment. Ann Oncol 15:1237–1242

    Article  PubMed  CAS  Google Scholar 

  6. Durstine JL, Painter P, Franklin BA, Morgan D, Pitetti KH, Roberts SO (2000) Physical activity for the chronically ill and disabled. Sports Med 30:207–219

    Article  PubMed  CAS  Google Scholar 

  7. Flaherty KR, Wald J, Weisman IM, Zeballos RJ, Schork MA, Blaivas M, Rubenfire M, Martinez FJ (2001) Unexplained exertional limitation: characterization of patients with a mitochondrial myopathy. Am J Respir Crit Care Med 164:425–432

    PubMed  CAS  Google Scholar 

  8. Ganz PA, Moinpour CM, Pauler DK, Kornblith AB, Gaynor ER, Balcerzak SP, Gatti GS, Erba HP, McCoy S, Press OW, Fisher RI (2003) Health status and quality of life in patients with early-stage Hodgkin’s disease treated on Southwest Oncology Group Study 9133. J Clin Oncol 21:3512–3519

    Article  PubMed  Google Scholar 

  9. Heidenreich PA, Hancock SL, Lee BK, Mariscal CS, Schnitter I (2003) Asymptomatic cardiac disease following mediastinal irradiation. J Am Coll Cardiol 42:743–749

    Article  PubMed  Google Scholar 

  10. Kaufmann SH, Earnshaw WC (2000) Induction of apoptosis by cancer chemotherapy. Exp Cell Res 10:42–49

    Article  CAS  Google Scholar 

  11. Knobel H, Loge JH, Lund MB, Forfang K, Nome O, Kaasa S (2001) Late medical complications and fatigue in Hodgkin’s disease survivors. J Clin Oncol 19:3226–3233

    PubMed  CAS  Google Scholar 

  12. Loge JH, Abrahamsen AF, Ekeber O, Kaasa S (1999) Hodgkin’s disease survivors more fatigued than the general population. J Clin Oncol 17:253–261

    PubMed  CAS  Google Scholar 

  13. Oldervoll LM, Kaasa S, Knobel H, Loge JH (2003) Exercise reduces fatigue in chronic fatigued Hodgkin’s disease survivors—results from a pilot study. Eur J Cancer 39:57–63

    Article  PubMed  CAS  Google Scholar 

  14. Ruffer JU, Flechtner H, Tralls P, Josting A, Sieber M, Lathan B, Diehl V, German Hodgkin Lymphoma Study Group (2003) Fatigue in long-term survivors of Hodgkin’s lymphoma: a report from the German Hodgkin Lymphoma Study Group (GHSG). Eur J Cancer 39:2179–2186

    Article  PubMed  CAS  Google Scholar 

  15. Seymour JF, Talpaz M, Hagemeister FB, Cabanillas F, Kurzrock R (1997) Clinical correlates of elevated serum levels in interleukin 6 in patients with untreated Hodgkin’s disease. Am J Med 102:21–28

    Article  PubMed  CAS  Google Scholar 

  16. Villani F, Villani S, Bonfante V, De Maria P, Soncini F, Laffranchi A (2000) Late pulmonary effects in favorable stage I and IIA Hodgkin’s disease treated with radiotherapy alone. Am J Clin Oncol 23:18–21

    Article  PubMed  CAS  Google Scholar 

  17. Villani F, Fede Catania A, Laffranchi A, Maffioli L, Viviani S, Bonfante V (2003) Effect of an intensive chemotherapy followed by mediastinal irradiation on pulmonary and cardiac function in advanced Hodgkin’s disease. Cancer Invest 21:185–192

    Article  PubMed  CAS  Google Scholar 

  18. Wasserman K, Hansen JE, Sue DY et al (1994) Protocols for exercise testing. In: Wasserman K (ed) Principles of exercise testing and interpretation: including pathophysiology and clinical applications, 2nd edn. Lea & Febiger, Philadelphia, pp 58–71

    Google Scholar 

  19. Weisman IM, Zaballos RJ (2002) An integrative approach to the interpretation of cardiopulmonary exercise testing. Prog Respir Res 32:300–322

    Article  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Eric Page.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Page, E., Assouline, D., Durand, C. et al. Stage-related changes in functional capacity in Hodgkin’s disease: assessment by cardiopulmonary exercise testing before initiation of treatment. Ann Hematol 85, 857–861 (2006). https://doi.org/10.1007/s00277-006-0174-5

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00277-006-0174-5

Keywords

Navigation